SEC Form 4 · accession 0001144204-17-042179
Aevi Genomic Medicine, Inc. · GNMX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph J Grano Jr.
Director
Period of report
Jun 22, 2017
Accepted (ET)
Aug 10, 2017 · 9:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001138776
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option Award (right to buy) | $1.32 | Jun 22, 2017 | A | 20,000 | A | Jun 22, 2018 | Jun 22, 2027 | Common Stock | 20,000 | 20,000 | D |